4 results
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... between oral agents ... the timing and dosing ... #conversion #Clopidogrel ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... - Switching Between ... inhibitors during ... #conversion #Clopidogrel ... ticagrelor #prasugrel #pharmacology
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... and Dosing #Management ... #Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANTAGONIST (ARB) DOSING ... BETWEEN AGENTS ... Doses should be ... ReceptorBlocker #Pharmacology ... #Conversion #Switching